Poonawalla Fincorp Limited (NSE:POONAWALLA)
India flag India · Delayed Price · Currency is INR
434.00
-10.50 (-2.36%)
Aug 8, 2025, 3:30 PM IST

Verve Therapeutics Revenue

Poonawalla Fincorp had revenue of 5.27B INR in the quarter ending June 30, 2025, a decrease of -14.34%. This brings the company's revenue in the last twelve months to 11.53B, down -49.69% year-over-year. In the fiscal year ending March 31, 2025, Poonawalla Fincorp had annual revenue of 12.41B, down -41.27%.

Revenue (ttm)
11.53B
Revenue Growth
-49.69%
P/S Ratio
29.84
Revenue / Employee
3.21M
Employees
3,594
Market Cap
344.06B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202512.41B-8.72B-41.27%
Mar 31, 202421.14B6.07B40.30%
Mar 31, 202315.07B4.92B48.48%
Mar 31, 202210.15B11.73B-741.99%
Mar 31, 2021-1.58B-9.74B-119.38%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition